Primary Care for HIV-Infected Patients in Resource-Limited Settings

  • Authors: Charles van der Horst, MD; F. Parker Hudson, MD (More Info)
  • Editors in Chief: Daniel R. Kuritzkes, MD; Joseph J. Eron, Jr., MD
  • Last Reviewed: 9/4/18 (What's New)

Summary

  • As part of the WHO recommendation that all persons diagnosed with HIV infection initiate ART regardless of WHO clinical stage or CD4+ cell count, all pregnant women should initiate lifelong triple-drug ART, even if diagnosed late in pregnancy or postpartum (Management Guidelines)[WHO ART]
    • Preferred first-line regimen in all pregnant and breastfeeding women—including those in the first trimester—is tenofovir, lamivudine (or emtricitabine), and efavirenz
    • If an efavirenz-based regimen cannot be used, a nevirapine-containing regimen may be used as an alternative but should be used with caution

Action required

Keywords: Biomedical Prevention, Initial Antiretroviral Therapy, Resource-Limited Settings, Special Populations

©2018 Clinical Care Options, LLC. All Rights Reserved.

The materials published via inPractice® reflect the views of the reviewers or authors of the material, not those of Clinical Care Options, LLC, the accredited provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.